Relay Therapeutics's total assets for Q1 2026 were $699.61M, an increase of 12.60% from the previous quarter. RLAY total liabilities were $57.43M for the fiscal quarter, a 5.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.